Tackling the MDR-TB epidemic in Ukraine: every little helps … and much more needed.
Centre for Primary Care and Public Health, Queen Mary University of London,London,UK.
Matthew
M
Burman
Public Health England, National Mycobacterium Reference Service South, London, UK.|Imperial College, London, UK.
Vladyslav
V
Nikolayevskyy
Department of Medicine, Infectious Diseases and Immunity, Imperial College London, London, UK.
Irina
I
Kontsevaya
Institut Germans Trias i Pujol (IGTP),Universitat Autònoma de Barcelona, Barcelona,Spain.
Barbara
B
Molina-Moya
Department of Chemistry,Umeå University, Umeå, Sweden.
Olena
O
Rzhepishevska
Centre Hospitalier de Bligny, Briis-sous-Forges, France.|Center of Immunology and Infectious Diseases, Sorbonne Université, Paris, France.
Lorenzo
L
Guglielmetti
D000995:Antitubercular Agents / Q000600:supply & distribution* / Q000627:therapeutic use; D058872:Epidemics / Q000517:prevention & control*; D006801:Humans; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D014455:Ukraine / Q000453:epidemiology
D000995:Antitubercular Agents